Inhibition of bromodomain and extra-terminal proteins targets constitutively active NFκB and STAT signaling in lymphoma and influences the expression of the antiapoptotic proteins BCL2A1 and c-MYC
Nadja M. Pieper(Goethe University Frankfurt), Meike Vogler(Goethe University Frankfurt)
Cited by 3
Related Papers
BCL2/BCL-XL inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation
|Blood|2011|189
CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells
|Nature Communications|2024|71
CRISPR/Cas9 Gene Editing of Immune Checkpoint Receptor NKG2A Improves the Efficacy of Primary CD33-CAR-NK Cells Against AML
|Blood|2022|22
Precision targeting of rhabdomyosarcoma by combining primary CAR NK cells and radiotherapy
|Journal for ImmunoTherapy of Cancer|2025|8